Datum Dental Ltd. provides innovative regenerative solutions to support and enhance the future of implantology and oral care. The company markets its products for dental professionals through its extensive global network of over 20 partners in more than 35 countries worldwide.

Datum Dental, affiliated with Datum Biotech, uses its patented GLYMATRIX^® core technology, a sugar cross-linking collagen biomaterial, for guided bone regeneration (GBR) and guided tissue regeneration (GTR) — clinically proven in over 100 scientific publications. Powered by GLYMATRIX, the OSSIX^® product family has enabled clinicians in hundreds of thousands of procedures spanning almost two decades to safely provide predictable, long-term results to their patients.

The OSSIX regenerative solutions portfolio includes legacy OSSIX^® Plus ossifying collagen barrier membrane, OSSIX™ Bone ossifying mineralized collagen sponge, and OSSIX® Volumax ossifying, volumizing collagen scaffold. Datum Dental’s R&D pipeline continues to develop new products for GBR and GTR that simplify procedures and overcome major deficiencies in existing biomaterials through safe and transformational solutions.